Compliance in Healthcare and ResearchISBN: 978-0-87993-474-3
Hardcover
354 pages
July 2001, Wiley-Blackwell
 Add to Cart
This price is valid for United States. Change location to view local pricing and availability.  |
Contributors.
PART I. Introduction.
Improving Patient Adherence: State of the Art, With A Special Focus on Medication Taking for Cardiovascular Disorders.
R. Brian Haynes, MD, PhD.
PART II. Factors and Interventions Affecting Compliance .
Chapter 1. Predicting Compliance.
Deborah J. Bowen, PhD, Almut Helmes, MS, and Erika Lease, BA .
Chapter 2. Strategies to Increase Adherence to Treatment.
Judith K. Ockene, PhD, MEd .
Chapter 3. Behavioral Strategies to Improve Medication-Taking Compliance.
Elizabeth A. Schlenk, PhD, RN, Lora E. Burke, PhD, RN, and Cynthia Rand, PhD, .
.
PART III. Multi-Level Organizational Approaches to Compliance .
Chapter 4. Provider Approaches to Improve Compliance.
Ira S. Ockene, MD.
Chapter 5. Organizational Approaches to Improve Compliance.
Thomas E. Kottke, MD, Leif Solbert, MD, and Milo Brekke, PhD,.
.
PART IV. Measurement of Compliance.
Chapter 6. Conceptual and Methodological Problems.
Jacqueline Dunbar-Jacob, PhD, RN, FAAN and Susan Sereika, PhD.
Chapter 7. Biological Measures.
John Urquhart, MD, FRCP (Edin).
Chapter 8. Electronic Measures.
Lora E. Burke, PhD, MPH, RN.
Chapter 9. Analysis of Electronic Event Monitored Adherence.
Susan M. Sereika, PhD and Jacqueline Dunbar-Jacob, PhD, RN, FAAN.
Chapter 10. Self-Report Data.
James R. Hebert, ScD, Yunsheng Ma, MD, MPH, Cara B. Ebbeling, PhD, Charles E.
Matthews, PhD, and Ira S. Ockene, MD.
.
PART V. Issues in Special Populations .
Chapter 11. Children.
Tom Baranowski, PhD, Janice C. Baranowski, MPH, RD, LD, and Karen Cullen, DrPH, RD, LD.
Chapter 12. Minority Populations.
Shiriki K. Kumanyika, PhD, MPH, RD.
Chapter 13. Obese Populations.
Michael G. Perri, PhD.
.
PART VI. Issues Across Settings .
Chapter 14. Clinical Trials.
Eleanor Schron, MS, RN and Susan M. Czajkowski, PhD.
Chapter 15. Treatment Targets.
Harlan M. Krumholz, MD, Mohsen Davoudi, MD, Joan M. Amatruda, RN, and Sarah A.
Roumanis, RN.
.
PART VII. Special Topics.
Chapter 16. Analysis of Clinical Trials and Treatment Nonadherence.
Susan M. Sereika, PhD and Ed Davis, MD.
Chapter 17. Compliance of Providers to Guidelines.
Thomas A. Pearson, MD, PhD and Laurie A. Kopin, ANP.
Chapter 18. Impact of Compliance on Clinical Outcomes.
Michel Burnier, MD and Hans R. Brunner, MD.
Chapter 19. Managed Care.
Thomas H. Lee, MD, MSc.
PART VIII. Future Directions .
Chapter 20. Innovative Approaches to Compliance.
Deborah J. Aaron, PhD, MSIS, Kimberly A. Morris, PhD, Patricia A. Nixon, PhD, Jeffrey.
P. Martin, MBA, Deborah Echement, BA, and Ronald E. LaPorte, PhD.
Chapter 21. Future Directions: What Paths Do Researchers Need to Take? What Needs to be Done to Improve Multi-Level Compliance?.
Neil B. Oldridge, PhD
PART I. Introduction.
Improving Patient Adherence: State of the Art, With A Special Focus on Medication Taking for Cardiovascular Disorders.
R. Brian Haynes, MD, PhD.
PART II. Factors and Interventions Affecting Compliance .
Chapter 1. Predicting Compliance.
Deborah J. Bowen, PhD, Almut Helmes, MS, and Erika Lease, BA .
Chapter 2. Strategies to Increase Adherence to Treatment.
Judith K. Ockene, PhD, MEd .
Chapter 3. Behavioral Strategies to Improve Medication-Taking Compliance.
Elizabeth A. Schlenk, PhD, RN, Lora E. Burke, PhD, RN, and Cynthia Rand, PhD, .
.
PART III. Multi-Level Organizational Approaches to Compliance .
Chapter 4. Provider Approaches to Improve Compliance.
Ira S. Ockene, MD.
Chapter 5. Organizational Approaches to Improve Compliance.
Thomas E. Kottke, MD, Leif Solbert, MD, and Milo Brekke, PhD,.
.
PART IV. Measurement of Compliance.
Chapter 6. Conceptual and Methodological Problems.
Jacqueline Dunbar-Jacob, PhD, RN, FAAN and Susan Sereika, PhD.
Chapter 7. Biological Measures.
John Urquhart, MD, FRCP (Edin).
Chapter 8. Electronic Measures.
Lora E. Burke, PhD, MPH, RN.
Chapter 9. Analysis of Electronic Event Monitored Adherence.
Susan M. Sereika, PhD and Jacqueline Dunbar-Jacob, PhD, RN, FAAN.
Chapter 10. Self-Report Data.
James R. Hebert, ScD, Yunsheng Ma, MD, MPH, Cara B. Ebbeling, PhD, Charles E.
Matthews, PhD, and Ira S. Ockene, MD.
.
PART V. Issues in Special Populations .
Chapter 11. Children.
Tom Baranowski, PhD, Janice C. Baranowski, MPH, RD, LD, and Karen Cullen, DrPH, RD, LD.
Chapter 12. Minority Populations.
Shiriki K. Kumanyika, PhD, MPH, RD.
Chapter 13. Obese Populations.
Michael G. Perri, PhD.
.
PART VI. Issues Across Settings .
Chapter 14. Clinical Trials.
Eleanor Schron, MS, RN and Susan M. Czajkowski, PhD.
Chapter 15. Treatment Targets.
Harlan M. Krumholz, MD, Mohsen Davoudi, MD, Joan M. Amatruda, RN, and Sarah A.
Roumanis, RN.
.
PART VII. Special Topics.
Chapter 16. Analysis of Clinical Trials and Treatment Nonadherence.
Susan M. Sereika, PhD and Ed Davis, MD.
Chapter 17. Compliance of Providers to Guidelines.
Thomas A. Pearson, MD, PhD and Laurie A. Kopin, ANP.
Chapter 18. Impact of Compliance on Clinical Outcomes.
Michel Burnier, MD and Hans R. Brunner, MD.
Chapter 19. Managed Care.
Thomas H. Lee, MD, MSc.
PART VIII. Future Directions .
Chapter 20. Innovative Approaches to Compliance.
Deborah J. Aaron, PhD, MSIS, Kimberly A. Morris, PhD, Patricia A. Nixon, PhD, Jeffrey.
P. Martin, MBA, Deborah Echement, BA, and Ronald E. LaPorte, PhD.
Chapter 21. Future Directions: What Paths Do Researchers Need to Take? What Needs to be Done to Improve Multi-Level Compliance?.
Neil B. Oldridge, PhD
Buy Both and Save 25%!
Compliance in Healthcare and Research (US $97.95)
-and- 101 Things To Do with Spare Moments on the Ward (US $25.95)
Total List Price: US $123.90
Discounted Price: US $92.92 (Save: US $30.98)
